unichem final project report

Introduction to Organization Study

Introduction:

This is an overall study of the organization of Unichem laboratory Ltd. where it’s

working environment and various policies and practice are studied

OBJECTIVES OF THE STUDY:

1. To familiarize with a business organization

2. To familiarize with the different departments in the organization and

their functioning.

3. To enable to understand how the key business process are carried out in

organizations.

4. Understand how information is used in organization for decision making at

various levels.

5. To know the history about the company.

6. To get clear cut idea about the management and administration.

7. To know about the industrial relation in the company.

8. To analyze the strength and weakness.

9. To get clear cut idea about the various departments and functions.

10. To give findings and solutions.

11. To relate theory with practice.

City College Dept. of Management Studies 1

INDUSTRY PROFILE

The Indian pharmaceutical industry is one of the developing world’s largest and most

developed, ranking 4th in the world in terms of production volume and 13th in

domestic consumption value. India’s industry, valued at $5.3 billion in 2005,

represents less than one percent of the global pharmaceutical industry ($550 billion).

Over the last 30 years, India’s pharmaceutical industry has evolved from almost

nonexistent to a world leader in the production of high quality generic drugs. India

has garnered a worldwide reputation for producing high quality, low cost generic

drugs. The industry currently meets India’s demand for bulk drugs and nearly all its

demand for formulations, with the remainder supplied by foreign multinational

corporations (MNCs). India’s pharmaceutical industry is one of the fastest growing

segments of the Indian economy with an average annual growth rate of 14 percent

during 2002-2005. Overall, the Indian market for pharmaceuticals is projected to

grow at an average annual rate of between 15 and 20 percent during 2005-2010. The

surge in production has been driven by legislative reforms, the growth in contract

manufacturing and outsourcing, value added foreign acquisitions and joint ventures,

India’s mastery of reverse engineering of patented drug molecules, and India’s efforts

to comply with its World Trade Organization (WTO) Trade Related Intellectual

Property Agreement obligations. When India joined the WTO in 1995, its

pharmaceutical exports were valued at less than $600 million. By 2005, its exports

had grown to $3.7 billion and accounted for more than 61 percent of industry

turnover. Currently, Indian pharmaceutical companies produce between 20 and 22

percent of the world’s generic drugs (in value terms) and offer 60,000 finished

medicines and nearly 400 bulk drugs used in formulations.4 With changes in India’s

patent laws in the early 1970s, Indian drug producers became experts in ‘reverse

engineering’ and increased its supply of less expensive copies of the world’s best-

selling patent protected drugs. India’s pharmaceutical industry grew and prospered in

a highly regulated environment with government price controls on a significant

number of formulations and bulk drugs. In January 2005, India amended its patent

laws governing pharmaceuticals, bringing them into conformance with the WTO

TRIPs agreement. Under the new patent law, Indian drug markers can no longer

manufacture and market reverse-engineered versions of drugs patented by foreign


drug producers. To replace sales lost to TRIPs compliance, many of India’s leading

pharmaceutical producers have increased their exports of generic drugs to the United

States and Western Europe and entered into research and development agreements,

mergers and acquisitions, and other alliances with foreign pharmaceutical firms.

India’s Pharmaceutical industry: Independence to 2005

At the time of independence in 1947, India’s pharmaceutical market was dominated

by Western MNCs that controlled between 80 and 90 percent of the market primarily

through importation. Approximately 99 percent of all pharmaceutical products under

patent in India at the time were held by foreign companies and domestic Indian drug

prices were among the highest in the world. The Indian pharmaceutical market

remained import-dependent through the 1960s until the government initiated policies

stressing self-reliance through local production.5 At that time, 8 of India’s top 10

pharmaceutical firms, based on sales, were subsidiaries of MNCs. To facilitate an

independent supply of pharmaceutical products in the domestic market, the

government of India founded 5 state-owned pharmaceutical companies.6 Today, India

is the world’s fifth largest producer of bulk drugs. Government policy culminated in

various actions including: the abolition of product patents on food, chemicals, and

drugs; the institution of process patents; the limitation of multinational equity share in

India pharmaceutical companies, and the imposition of price controls on certain

formulations and bulk drugs. Subsequently, most foreign pharmaceutical

manufacturers abandoned the Indian market due to the absence of legal mechanisms

to protect their patented products. Accordingly, the share of the domestic Indian

market held by foreign drug manufacturers declined to less than 20 percent in 2005.

As the MNCs abandoned the Indian market, local firms rushed in to fill the void, and

by 1990, India was self-sufficient in the production of formulations and nearly self-

sufficient in the production of bulk drugs.

Strengths and weaknesses of India’s pharmaceutical industry:

India’s comparative advantages lie in its cost competitiveness, its reverse engineering

experience, its large pool of less expensive English-speaking scientific and

engineering workers, and its well-developed chemical industry infrastructure.Today,

India produces some of the cheapest drugs in the world, especially because labor costs

are 50 to 55 percent cheaper than in the West.50 Industry experts indicate that


infrastructure costs are 40 percent lower and fixed cost are estimated to be 12 percent

to 20 percent less that in the United States and Western Europe. Consequently, India

can produce bulk drugs that cost 60 percent less that in the West and can open a

production plant in India 40 percent cheaper than in developed countries. Because of

this, India has become a hub for pharmaceutical research and development and

clinical trials for many leading foreign pharmaceutical companies.


COMPANY PROFILE

Introduction:

In Himachal Pradesh, the 'Dev Bhumi' or the land of the gods, renowned in India for

its mythological nexus and beautiful landscapes, is situated an upcoming industrial

township - Baddi.

Baddi is located about 45 kms from the architectural paradigm, Chandigarh, the town

is surrounded by lush green hills of the Shivalik range of mountains. In the far end of

the town, at the foothills, you come across a structure, which nestles in its ambiance, a

visual delight. This is the state-of-the-art pharmaceutical manufacturing unit of

Unichem Laboratories Limited, merging aptly into its backdrop, yet starkly standing

alone in its individuality.

The World class Baddi plant houses the manufacturing facility for different

formulations of Beta Lactam range of antibiotics.

Unichem brings to the customer a blend of modern-day research and nearly six

decades of rich experience in the Indian pharmaceuticals industry. The Company was

promoted by the late Mr. Amrut Mody, a pioneer in the Indian pharmaceuticals

business.

Even though formulations account for a significant portion of Unichem's revenues,

the Company also manufactures active pharmaceutical ingredients (API or bulk

actives). The Company has prudently addressed relevant and growing therapeutic

areas like gastro-intestinal, cardiovasculars, diabetes, psychaitry, neurology, anti-

bacterials, anti-infectives and pain management, among others.

Unichem is headquartered in Mumbai with five manufacturing locations in Roha

(Maharashtra), Goa, Ghaziabad (Uttar Pradesh), Pithampur (Madhya Pradesh) and

Baddi (Himachal Pradesh). The Company's facilities enjoy credible certifications: for

instance, the Goa plant has been approved by UK MHRA (earlier MCA), MCC

(South Africa), WHO (Geneva) and TGA (Australia). The Baddi plant has been


approved by UK MHRA and MCC (South Africa). The Company has received ISO

9001:2000 for all its plants and corporate office. Similarly the Company has received

ISO14001:1996 certificates for its formulation plants ( Goa, Ghaziabad and Baddi)

and Corporate Office at Mumbai.

As a future-focused initiative. Unichem has expanded its Research and Development

facility in Jogeshwari (Mumbai) to spearhead research in Novel Drug Delivery

Systems (NDDS) and develop non-infringing routes for the manufacture of products

directed at the regulated markets. The Company has also funded a collaborative

research with the Indian Institute of Sciences, Bangalore. Unichem's growth strategy

is fueled and backed by more than 2400 talented and motivated human resources.

Product manufactured in Baddi plant of UNICHEM LABS. LTD.:-

Beta lactum antibodies

Ampillin and cloxacillin antibodies.

Ampoxin (injection, capsules, kid tabs, neonate, & dry syrup)

Sulbacin injection.

Mymox capsules.

Myclave tablets.

Unienzyme tablets.


BADDI PLANT VIEW:-

Regulatory Approvals

Approved by World Premier Regulatory Bodies - WHO, MCC - South Africa

and MHRA-UK.

Installed Capacity

Dosage Form Million/Annum/Per shift

Capsules 225

Vials 20

Tablet 48

Dry Syrup 06


HISTORY/Milestones:-

2006

Unichem Specialities Division Launched

Acquisition of 100% stake in Niche Generics Limited, United Kingdom

2005

Set up of New Pharma Technology Development Center at GOA

Baddi Unit II plant was commissioned

Unichem acquired API manufacturing unit at Pithampur

2004

Restructuring of Unisearch & Launch of Unisearch CD Division

2002-2003

Animal Healthcare division divested

Subsidiaries in South Africa & Brazil established

Modernization of Ghaziabad formulations plant

2002

Established Joint Venture in UK called Niche Generics Limited

2001

New R&D Centre set up at Mumbai.

New Biosciences R&D Centre set up at Bangalore for research work in Bio-

technology

2000

Corporate Vision till 2005 unfolded

South African Health Authority Certifications for Goa and Baddi Plants

Bonus Issue 1:1

UK MCA (MHRA) certification for Goa & Baddi Plants


1999

Modern Multipurpose Bulk Drug plant set up at Roha

MOLECULAR GENERICS DIVN Launched

1998

Baddi formulations plant fully operational

1997

Goa formulations plant fully operational

New Corporate office set up at Unichem Bhavan Jogeshwari, Mumbai.

1996

Merger of Unichem Exports Ltd. & Unisearch Ltd. with Unichem

Laboratories Ltd

1994

Bonus Issue

First major capital infusion in the Company. Private Placement of shares @

Rs. 265 premium

1993

Right issue @ Rs.40/- per share

Restructuring & transformation of the company inline with future growth

strategies

1987

Entered Animal Health Care business

1986

Bonus Issue


1984

UNISEARCH Ltd. set up in Collaboration with Upjohn

Unichem entered the anti-biotic segment - Ampoxin launched

1983

US FDA approval for Hydrochlorothiazide at Jogeshwari plant

Anti-TB - Isoniazid, Rifampicin introduced in white tablet form for the first

time in India – Anticox

1979

NEFEDIFINE - Unichem first to get clearance from Drug Authorities

1978

Bonus Issue 1:4

Roha Bulk Drug Plant established (Backward Integration)

1976

Fine Chemicals unit at Roha was set up

1975

Bonus Issue 1:7

1973

Unichem's Research Laboratory recognised for Phd work by Bombay

University. Unichem's R&D Centre recognised by Department of Science &

Technology

1972

Padma Bhushan awarded to Late Mr. Amrut Mody for his pioneering efforts

in Indian Pharma Industry

1970

Backward Integration for manufacture of Anti-TB Drugs


1968

Ghaziabad formulations plant setup

1963

Tie up with Uni Sankyo - Co-Marketing formulations

1962

Foreign Collaboration with UCB for bulk-drugs

First Formulation plant at Jogeshwari

Unichem became Public-Listed on BSE - Total Share Capital 44 lacs

(October)

OESTROGEN & Progestin combinations launched

1953

Unichem entered into Hormonal products

UNIPROGESTIN launched

1952

First exports of Unichem

1944

Unichem was set up by Late Mr. Amrut Mody

ORGANISATIONAL CHART


Board of Directors

Managing Director

Vice President HRD &

Personnel

Vice President

R&D

Vice President Projects

Vice President

Marketing

Regional Sales

Manager

Sales Officer

Market Intelligent Assistants

HRD Manager

Assistants Manager Accnts

Manager Tax

Factory Accnts.

HRD Manager

Quality Assts.

Project Manager

Asst. Mrkg. Mgr

Field Officers

Market Intelligent System

Marketing Manager

Vice President Finance

Vice President

Sales

Regional Mrkg. Mgr

Asst. Manager


ORGANISATIONAL CHART OF PANNNISSERY UNIT

DIRECTOR V. PRSDNT

MAINT. DEPT

ACNTS DEPT

STORE DEPT

R&D DEPT

PURCHS

DEPT.

QLTY DEPT.

PRODN. DEPT

PERS DEPT

MAINT. IN-CHRG

STR KEEPER

PUR .IN CHARGE

PROD. IN CHARGE

ACCOUNTANT

R&D IN-CHRG

QLTY CTRL CHMST

PERS. IN-CHRG

MAINT. STAFF

ASSTS. ASSTS.

SUPRVSR

WORKMEN

BOARD OF DIRECTORS


Dr. Prakash Amrut Mody

Dr. Prakash Amrut Mody is a doctorate in Organic Medicinal Chemistry from

University of Bombay and graduate alumni of Harvard Business School. He is

associated with various industry associations. He serves on the Board of M/s. Kewal

Kiran Clothing Limited and on all Subsidiary Companies of Unichem. He was

appointed Chairman and Managing Director in 1999. He is the Chairman of the

Management Committee of Unichem.

Mr. Bhoopendra Kumar Sharma

Mr. Bhoopendra Kumar Sharma holds a Masters degree in commerce from Agra

University and a Postgraduate Diploma in Personnel Management from Delhi

University. He was appointed as our Executive Director in 1994. Prior to this

appointment he was Vice President in charge of operations and marketing since 1989.

He joined the Company in 1969 and was in charge of operations of our Ghaziabad

plant till 1989.He serves on the Board of all Subsidiary Companies of Unichem. He

has served on the Board of Unichem since 1994. He is a member of the Management

Committee and Shareholders Grievance Committee of Unichem.

Mr. Prafull Anubhai

Mr. Prafull Anubhai, is a management consultant and is associated with educational,

research and cultural institutions like Indian Institute of Management (IIMA),

Ahmedabad Education Society (AES), Centre for Science Technology and Policy

(CSTEP), ATIRA, Saptak (An Indian Classical Music organization) etc. He has done

his B.Sc.(Econ.) from the London School of Economics and attended PMD at

Harvard Business School. He has 30 years of experience in top management of

Textile and other businesses. He serves on the Boards of Torrent Cables Ltd., The

EMSAF – Mauritius (The Emerging Markets South Asia Fund), Mahavir Spinning

Mills Ltd. (Vardhman Group), Birla Sun Life Trustee Co. Pvt. Ltd. etc. He has served

on the Board of Unichem since 1979. He is the Chairman of the Audit Committee and

member of the Compensation Committee of Unichem.

Mr. Ramdas M Gandhi


Mr. Ramdas M Gandhi is an advocate and solicitor by profession. He holds a Masters

degree in law from University of Bombay. He was enrolled as an attorney at law in

the High Court of Mumbai in 1956. He also served as partner in a leading law firm in

India namely M/s. Bhaishanker Kanga & Girdharlal, and of M/s. Manilal Kher

Ambalal & Co. He presently serves as director in Pidilite Industries Limited, Aarti

Industries Limited, Vinyl (India) Chemicals Limited and Aarti Drugs Limited. He has

served on the Board of Unichem since 1985. He is the Chairman of the Shareholders

Grievance Committee and member of Audit Committee, Compensation Committee

and Management Committee of Unichem.

Mr. Nasser Munjee

Mr. Nasser Munjee holds a bachelor degree in economics from the London School of

economics, a master of economic degree from the London School of economics.

Presently, he is Chairman of Development Credit Bank Limited. He has served as

Managing Director and CEO of Infrastructure Development Finance Company and as

Executive Director of Housing Development Finance Corporation. He also has

handled consultancy assignments of World Bank, Asian development bank, UN

Habitat Centre and UNCDF. He serves on the Board of many leading Indian and

multinational companies including Cummins India, Gujarat Ambuja Cements

Limited, HDFC Limited, Voltas Limited, Maharashtra Airport Development

Company Limited, etc. He has served on the Board of Unichem since 2003. He is a

member of the Audit Committee of Unichem.

Mr. Prafull D. Sheth

Mr. Prafull D. Sheth currently serves as Vice-President, Federation of Asian

Pharmaceutical Association, Manila, Philippines, Professional Secretary, SEAR

Pharma Forum (South East Asian FIP-WHO Forum of National Pharmaceutical

Associations) and Member, Executive Committee, Community Pharmacy Section,

International Pharmaceutical Federation. He has served as Executive Director of M/s.

Ranbaxy Laboratories Limited, and as President of Indian Pharmaceutical

Association. He has been on the Board of Unichem since 2003. He is the Chairman of

the Compensation Committee of Unichem.

Mr. Anand Y Mahajan


Mr. Anand Y Mahajan is the Managing Director of Grindwell Norton Limited and the

General Delegate of Compagnie de Saint-Gobain responsible for India, Sri-Lanka and

Bangladesh. He has served on the Board of Unichem since 2005.


VISION

"To be a global Pharmaceutical company with increasing focus on innovative

research and developed markets"

MISSION

"To be a caring Pharmaceutical company helping to enhance health through quality

products"

OBJECTIVES OF THE COMPANY

1. To setup and carry out research and development for the manufacture

and development of antiseptic soaps, toothpastes, tooth powder etc...

2. To carry out the business as manufactures, producers, investors,

converters, sellers, packers, movers, stockiest, agents, merchants,

distributors, consignors, jobbers, or otherwise deal in all kinds and

varieties of products used for as personal care, health care etc. But in

future company has a plan to produce anti HIV drugs.

SOCIAL OBJECTIVES

Provide employment to the people, who live in and around the

production units

Increase the standard of living of the people

Carry out good business practices for the enrichment of the society as a

whole

Contribute to the nations wealth

Extends help for the promotion of education and for the welfare of the

society


PRODUCT PROFILE:-

1. Active Pharmaceutical Ingredients

Sr.

No.

Current Product List Therapeutic uses

1 Amlodipine Besylate Anti Hypertensive

2 Amlodipine Maleate Anti Hypertensive

3 Bendroflumethiazide Anti Hypertensive, Diuretic

4 Bisoprolol Hemifumarate B-Blocker

5 Brimonidine Tartrate Anti Glucoma

6 Buprenorphine

Hydrochloride

Post Operative Analgesic

7 Clonidine Hydrochloride Anti Hypertensive

8 Hydrochlorothiazide Anti Hypertensive,Diuretic

9 Leflunomide Immunomodulator,

Antirheumatic

10 Meloxicam COX II Inhibitor

11 Metronidazole Anti Protozoal / Anti Amoebic

12 Sertraline Hydrochloride Anti Depressant

13 Telmisartan Anti Hypertensive

14 Tizanidine Hydrochloride Muscle Relaxant


ANOTHER PRODUCTS:-


Sr.

No.

Product List Therapeutic uses

1 Aripiprazole Antipsychotic

2 Eprosartan

Mesylate

Anti Hypertensive

3 Escitalopram Anti Depressant

4 Lamotrigine Anti Epileptic

5 Levetiracetam Anticonvulsant

6 Losartan

Potassium

Anti Hypertensive

7 Pantoprazole

Sodium

Anti Ulcerative

8 Rosuvastatin HMG-CoA Reductase Inhibitor

9 Zafirlukast Anti Asthmatic

10 Alfuzosin Alphablocker

11 Amiodarone Anti Arrhythmic

12 Erdosteine Mucolytic

13 Eszopiclone Anti Insomnia

14 Quetiapine

Hydrochloride

Anti Psychotic

15 Ranolazine Anti Anginal

16 Venlafaxine Anti Depressant

Proposed in

the near future

Veterinary Products:-

Having been deeply imbibed with the philosophy of quality and reliability, Agvet

Unichem has been the first to introduce many revolutionary veterinary products.

The division has the most unique range of veterinary products that encompasses many

facts of ailments and treatments.

Duraprogen*

The No. 1 Progesterone brand in the country, it is

essential for initiating and maintaining pregnancy.

A durable support for pregnancy.

UNIMYCIN*

The pioneering introduction of Neomycin

antibacterial in veterinary as an injection & bolus.

Superior pharmacokinetics and higher uterine

levels of Unimycin eliminates the necessity for

any other intra-uterine theraphy.

LIVOFEROL®

A liquid feed supplement for cattle & poultry,

containing Iron, B-complex, Calcium and Liver

Fraction.

An ideal vitalizer that enhances production and

increases profits.

FAZOLE®


A unique combination of two powerful antimicrobials against

anaerobic and aerobic micro organisms and protozoa.

UNIMIX*

A unique growth promoter & body defence booster.

It ensures a dual advantage of superior body weight gain and

increased body defence.


3. DEPARTMENT STUDY & SWOT ANALYSIS:

3.1 DEPARTMENTS/FUNCTIONAL AREAS:

City College Dept. of Management Studies

FunctionalArea

H.R.

DEPARTMENT

Manufacturing

DepartmentFinancial

DepartmentMarketing

Department

22

MANUFACTURING DEPARTMENT:-

Quality assurance Department

A separate quality assurance department is functioning in this unit to ensure

that all the products meet the required quality. The quality assurance dept. is

entrusted with the responsibility of preparing quality control plans and

measures and evaluating product quality.

Important Function

1. The department makes sure that the raw materials comply with the

quality specifications by collecting samples. Raw materials are accepted

if it conforms to specified quality and are rejected if the raw materials do

not comply with the specified quality.

2. The department checks the quality of output after the completion of each

stage of production.

3. The department attends the customer complaints on quality aspects and

takes corrective action.

4. The department ensures that necessary actions have been taken for the

assurance of quality of the final product


PURCHASE DEPARTMENT

The purchase department is responsible for the continuous availability of raw

material to the production department. The production department should see

that all the required materials are purchased at the right time in the right

quantity at the right price. Continuous availability of all the raw material are

necessary to keep the production flow uninterrupted. The company makes

purchases from suppliers outside as well as inside the state.

Purchase Procedure

The company prepares a detailed purchase budget at the beginning of every

year, which contains the item and quantity to be purchased of each item. The

bill of materials can also be used to know the requirement of raw materials for

a certain period of time. The purchase in-charge, after receiving the purchase

requisition form initiated by the storekeeper makes necessary arrangements for

inviting tender for supplier selection. The supplier selection then company

conducts vendor evaluation by collecting complete information about the

suppliers. While evaluating supplier’s information like creditworthiness, past

experience, delivery time, capacity to supply, mode of payment are collected

and evaluated. An approval list of suppliers is prepared after the completion of

vendor evaluation. After having selected the supplier, the purchase department

proceeds to place the order for materials, specifying the details of goods. The

purchase order contains details such as order number and date, suppliers name

& address, rate and number of items ordered, mode and date of delivery etc......

The dept sends reminder to supplier for the timely delivery of goods.

Goods are verified at the time of receiving with the help of delivery note sent

by the supplier and the purchase order. Quality assurance is done by quality

department by taking samples from the arrived materials. Goods are received

only after the completion of quality and quantity inspection. This follows the

preparation of material received note.


RESEARCH & DEVELOPMENT

BIOSICENCES R & D

Biosciences Research Centre, Unichem Laboratories Ltd., Bangalore

The Biosciences Research facility is located at the Indian Institute of Science

Campus, Bangalore.

This well equipped laboratory became functional in April 2002

The Research centre has initiated collaborations with renowned scientists at

the Indian Institute of Science.

The major focus is on biologically active peptides of therapeutic value.

The centre has scientific / technical expertise in the areas of modern biology /

chemistry.

The Biosciences Division also interfaces with the R&D centre located at

Jogeshwari to explore newer avenues for novel drug discovery.

CHEMICAL R&D

Resources

State of art facility in 35000 sq ft.

Highly talented creative & energetic synthetic & analytical team

Well equipped library with online web search facility

Speciality Areas

Asymmetric Synthesis, Grignard reactions, High pressure reactions.


STORES DEPARTMENT

Stores Department is responsible for storing materials and finished products.

Stores department is headed by storekeeper and he is assisted by assistants.

This unit has a centralized store and it is from here materials are dent to various

departments. The departments keep the finished good and all the raw materials

required for the production. Raw materials are issued according to the

requirements from respective departments.

Functions

1. The department checks the weights of the raw materials when they are

received.

2. The department issues raw materials to the production department.

3. The stores department maintains different types of books and registers for

the proper control of materials. Various records are maintained in stores

department are

1. Goods Received note

2. Stock Register

3. Material Purchase register

4. Quality Register (for recording items of low quality)


MAINTENANCE DEPARTMENT

The maintenance department is responsible for the smooth and proper working

of all the machines. This department ensures that all the machines are

maintained properly which is necessary for the uninterrupted flow of

production. The maintenance department is headed by maintenance in charge

and he is assisted by maintenance staff. The maintenance department performs

mainly 3 types of maintenance works namely

Preventive maintenance

Periodic Maintenance

Break down Maintenance

PRODUCTION PROCESS:-

City College Dept. of Management Studies

SIFTERS MILLS GRANULATORS

FLUID BED DRYERS & PROCESSORS

COMPRESSIONCOATINGBLISTER PACKING MACHINES

27

Composition:-

Unichem Pharma is the flagship division of Unichem Laboratories. The division has a

diverse portfolio of over 25 brands in the day therapy areas of Pain management, Anti

infectives, Anti allergics, Digestives and Nutritionals.The division has attained

leadership in key segments of Cephalosporins and Anti-allergics with brands that

have been launched in the past 3 to 4 years. Key among these are Sefdin a brand of

Cerfdinir and Lezyncet the leading brand by volumes in the Levocetirizine market.In

fact many brands of Unichem Pharma feature amonth the top three brands of the

respective segment and three of the brands rank among the top 300 in the Indian

pharmaceutical industry.

Sr.

No.

Name of the

Formulation and

composition

SpecificationCOMPOSITION

Type Size

1 Ampoxin 250 Strip 10CAmpicillin 125mg & Cloxacillin

125mg

2 Ampoxin 500 Strip 10CAmpicillin 250mg & Cloxacillin

250mg

3 Ampoxin 250 Vial VialAmpicillin 125mg & Cloxacillin

125mg

4 Ampoxin 500 Vial VialAmpicillin 250mg & Cloxacillin

250mg

5 Ampoxin 1Gm Vial VialAmpicillin 500mg & Cloxacillin

500mg

6 Ampoxin Neonate Vial VialAmpicillin 50mg & Cloxacillin

25mg

7 Ampoxin Dry Syrup Bottle 30MLAmpicillin 125mg & Cloxacillin

125mg

8 Ampoxin Kid Strip 10TAmpicillin 125mg & Cloxacillin

125mg

9 Ampoxin - LB 250 Strip 10C Ampicillin 125mg & Cloxacillin


mg125mg & Lactic acid Bacillus 60 X

106

10Ampoxin - LB 500

mgStrip 10C

Ampicillin 250 mg & Cloxacillin 250

mg & Lactic acid Bacillus 60 X 106

11 Anticox II Strip 4TRifampicin 450mg & Isoniazid I.P

300mg

12 Tuftax 0.75 G Vial VialCefotaxime 500 mg & Sulbactam 250

mg.

13 Tuftax 1.5 G Vial VialCefotaxime 1000 mg & Sulbactam 500

mg.

14 Celib 100 mg Strip 10 C Celecoxib 100 mg

15 Celib 200 mg Strip 10 C Celecoxib 200 mg

16 Domadol 50 mg Strip 10 C Tramadol Hydrochloride 50mg

17 Domadol 50 mg Ampoule5

*1MLTramadol Hydrochloride 50mg

18 Domadol 100 mg Ampoule 5*2ML Tramadol Hydrochloride 100mg

19 Erix 50 mg Strip 4T Sildenafil 50 mg

20 Flospar 200 mg Strip 6T Sparfloxacin 200mg

21 Frez DS Strip 10 TOfloxacin USP 200mg & Tinidazole

IP 600mg

22 Izra 20 mg Strip 10 T Esomeprazole 20 mg

23 Izra 40 mg Strip 10 T Esomeprazole 40 mg

24 M_Cam 15 mg Strip 10T Meloxicam 15mg

25 M_Cam 7.5 mg Strip 10T Meloxicam 7.5mg

26 Pronim Bottle 30ML Nimesulide 50mg

27 Pronim Bottle 60ML Nimesulide 50mg

28 Sefdin 300 mg Strip 6 C Cefdinir 300 mg

29 Sefdin Dry Syrup Bottle 30 ml Cefdinir 125 mg

30 Sefdin DT Strip 10 T Cefdinir 125 mg


31 Sefdin LB 300 Strip 6TCefdinir 300 mg, Lactic Acid Bacillus

60 million spores

32 Unienzyme Strip 10T

Fungal diastase (1:800) 20mg, Papain

30mg, Simethicone 50mg, Activated

Charcoal 75mg, Nicotinamide 25mg

33 Zyncet Strip 10T Cetrizine Dihydrochloride B.P 10mg

34 Zyncet Syrup Bottle 60ML Cetrizine Dihydrochloride B.P 5mg

35 Etoxib 60mg Strip 10 T Etoricoxib 60mg


FINANCIAL ANALYSIS:

Unichem Q1 FY06 Total Income at Rs. 1225.32 million and Net profit at Rs.

322.81 million

KEY HIGHLIGHTS:

Sales at Rs.1221.50 million as against Rs.1219.38 million in Q1 FY05; YoY

growth of 0.17%.

Profit before tax and extraordinary gains is at Rs.223.36 million in Q1 FY06

as against Rs.202.12 million in Q1 FY05. YoY growth of 10.51%

Net profit is at Rs 322.81 million as against Rs.144.05 million in Q1 FY05.

This translates to an annualized EPS of Rs.37.84 as against Rs.16.88 in Q1

FY05.


Un-audited Financials Results for the Quarter Ended June 30, 2005

All figures in Rupees Millions

INCOME 30th

Jun'05

30th

Jun'04

%

Change

Sales/Income from operations (Gross) 1221.50 1219.38 0.17

Other Income 3.82 2.37 61.18

TOTAL INCOME 1225.32 1221.75 0.29

TOTAL EXPENDITURE

(Increase) / Decrease in Closing stock of

Finished and Semi-finished goods

27.61 4.21 555.82

Consumption of Raw/Packing materials 264.05 305.78 -13.65

Excise Duty 66.14 98.02 -32.52

Purchase of Finished goods 191.27 189.37 1.00

Staff cost 116.77 100.70 15.96

Other expenditure 300.34 293.10 2.47

Interest 8.47 6.28 3

4.87

Depreciation 27.31 22.17 23.18

Profit before tax and Extraordinary gains 223.36 202.12 10.51

Extraordinary gain 133.87 0.00 133.87

Provision for Taxation (Including Deferred

Tax)

34.30 58.00 -40.86

Profit after tax and before prior period

items

322.93 144.12 124.07

Prior Period Expenses / (Income) 0.12 0.07 71.43

Net profit after tax, extraordinary gain and

prior period Items

322.81 144.05 124.10


Segmental Reporting (By Geographical Segment)

30th Jun'05 30th Jun'04 % Change

India 1050.25 1024.57 2.51

Outside India 171.25 194.81 -12.09

Total 1221.50 1219.38 0.17

Subsidiaries of Unichem

Niche Generics Limited, our United Kingdom subsidiary recorded sales of Rs214.60

million for Q1 FY06 as compared to Rs.157.10 Million during Q1 FY05

Dividend:-

Dividend payouts during the last five years are tabulated below:

Year Share Capital

(In Lacs)

Dividend Per Share (%) Total Dividend

(In Lacs)

2005-2006 1800.20 100 1800.20

2004-2005 1706.00 70 1194.00

2003-2004 1706.00 60 1024.00

2002-2003 853.00 80 682.40

2001-2002 853.00 80 682.40

Interim Dividend of 255.90 Lacs was declared as the final dividend for the

year 1999-2000.

Unichem expect to enhance value for shareholders in the future:-

Unichem's various initiatives are expected to generate sustainable growth. Unichem

will focus on a prudent management of debt and an increase in its return on net worth.

The pursuit of sound corporate governance initiatives are expected to protect

shareholder value and help build a business that generates a return on invested capital

that is higher than the industry average.

- Shares of Unichem are listed and traded on the Stock Exchange in Mumbai and the

National Stock Exchange of India Limited.

MARKETING DEPARTMENT


Marketing is a subject having wide spectrum. Marketing deals with the whole

process of entering markets, establishing profitable positions and building loyal

customer relationship. As market change, so does marketing. Marketing is no

longer a company department charged with a limited numbers of tasks.

Managing and advertising. Sending out direct mail, finding sales leads.

Providing customer service. It must drive the company’s vision, mission and

strategic planning. Marketing is about deciding who the company wants as its

customers, Which needs to satisfy, what products and services to offer, what

prices to set, what communications to send and receive. What channel of

distribution to use and what partnership to develop.

MARKETING STRATEGIES

All marketing strategies are built on STP- segmentation, targeting, and

positioning. Companies discover different needs and groups in the market

place, target those needs and groups that the companies can satisfy in a superior

way, and then positions its offering so

that the target market recognizes the companies distinctive offering and image.

No company can win, if its product and offering resembles every other product

and offerings. Today most companies are guilty of strategy convergence

namely undifferentiated strategies. Companies must pursue meaningful and

relevant positioning and differentiation. Companies normally reformulate their

marketing strategies and offerings several times. Economic condition changes,

competitors launch new and the produce passes through new stages of buyer

interests and requirements. Consequently strategies appropriate to each stage in

the products life cycle must be developed.


MARKETING STRATEGIES OF UNICHEM LABORATORY LTD.

Whole the marketing strategies of company is formulated and controlled by the

head office at mumbai directly. There is no involvement from the production

units situated at different part of the country.

The following are the marketing strategies adopted by the company:-

o To deliver quality products at reasonable prices to all the class of

the society.

o Differentials the products in order to get distinctive identity in the

market.

o Adopting sales promotional schemes for both the dealers and

customers.

o Creating brand awareness in the customers through continuous

advertisements and event sponsorship.

DISTRIBUTION CHANNELS

Marketing channels are set of interdependent organization involved in the

process of marketing a product or service available for use or consumption.

Channel decisions are among the most critical decision facing the management.

The channels chosen intimately affect all the other marketing decisions. The

distribution system is a key external source.

CHANNEL FUNCTIONS

They gather information about potential and current competitors and

other actors and forces in the marketing environment.

They develop and disseminate persuasive communications to stimulate

purchasing.

They reach agreement on price and other terms so that transfer of owner

ship or possession can be done easily

They place order with manufacturers.


They acquire the funds to finance investments at different levels in the

marketing channel.

They assume risk connected with carrying out channel work.

Channel of distribution of Unichem Laboratoty Ltd.

The Channel of distribution of the company is functioning very well to meet

the aim of reaching the product to customers at the right time. Following is the

chain of distribution of the company.

Super stockers

Distributors

Whole Sellers

Retailers

Finished products are taken by super stockers from the company and it is the

Super stockers who supply the products to the distributors.


ADVERTISEMENT

In today’s competitive business environment advertisement has got a crucial

role in the success of every business organization. No company can win the

competition if its advertisement strategies are not properly planned and created.

“Advertisement is any paid form of non-personal presentation and promotion

of ideas, goods or services by an identified sponsor”. Advertisement makes the

customers aware about the products and services of the company. It can be seen

that, behind the success of every products in that market, advertisement has

played an important role.

KINDS OF ADVERTISEMENT

Information advertising

Aims to create awareness and knowledge of new products or new features of

existing products.

Reinforcement advertising

Aims to convince current purchasers that they made the right choice.

Advertisement policy of Unichem Laboratory ltd.

The company makes use of various Medias to communicate its message and

product features to the customers. All the advertisement are planned and

implemented directly from the head office

Different advertisement Medias used by the company are as follows

Magazines

T.V. advertisement

Newspapers


Price of Animals product in Indian market:-

Quality with Economy:

Product Pack Size Price Available Active Drug Cost of treatment*

Helmigard 1.2g x 2 Rs. 25.60 2400 mg Rs. 21.33

Analgon 1.5g x 1 Rs. 20.00 1500 mg Rs. 26.66

Albomar 1.5g x 1 Rs. 20.00 1500 mg Rs. 26.66

Panacur 1.5g x 1 Rs. 28.00 1500 mg Rs. 37.33

Panfugal 1.5g x 1 Rs. 26.00 1500 mg Rs. 34.66

HUMAN RESOURCE DEPARTMENT


Personnel Department has got a vital role to play in every business

organization. It can be stated that without the active involvement personnel

dept. no work can be done in the organization whether it is production work or

managerial work. The Vice president heads the personnel dept. of Unichem

Labs Ltd. and he is assisted by managers and other staffs. All the recruitment

selection and Placement and salary fixation jobs are done by this Dept.

In this unit of Unichem Labs, there is a total strength of 100 employees the

number of managerial staff is 10. The packing of hand made detergent cake has

been contracted to a out side party. 50 employees are engaged in the packing

job. The contractor to whom the has been given fixes the remuneration of those

employees.

The overall working of this unit takes place in a single shift i.e. from 8.30 to

5.30 Two tea break and lunch break is given between this timing.

Function of Personnel Department

Salary computation

Salary disbursement

Leave Marking

Attendance

Manpower Planning

Recruitment

Transfer and promotion

Unichem lab Ltd obtain its employees for performing both administrative and

operative jobs through various modes. Lower level and middle level employee

are being selected from the local area itself where as managerial employees are

recruited by the following modes.

Newspaper Advertisement


Weekly Advertisement

Recruiting and selecting from other reputed companies

Transfer from other units

Selection procedure

The company place advertisement for the prospective employees and the

application received for different post are scrutinized by the personal dept. All

the application are scrutinized or the basis of the selection criteria followed by

the company. The company for different jobs has fixed different qualifications.

For production workers, technical qualification is compulsory where as for

managerial employees minimum qualification is graduation R&D and quality

assurance employees should have M.Sc in chemistry. Qualification for Finance

In-charge is C.A. with relevant experience.

Test

After having scrutinized the application received, next step is conducting

different tests. Tests are conducted to measure the candidate’s abilities like

1. Mental caliber

2. Physical Fitness

3. Subject Knowledge

4. Communication skill etc

Interview

Interview is a formal consolation to evaluate the aptitude of prospective

employee it is face- to- face and observation method to evaluate whether the

candidate is suited for the post to which he has applied After the interview the

interviewer comes to know about the skills and abilities of the candidate.

Final selection


Candidates who successfully complete the interview will be selected to the

particular job.

Placement and orientation

Placement is the final step in the selection process. It is the process of assigning

the employee with the job for which he/she has been selected. Proper

placement is necessary in order to avoid employee turnover. Proper placement

also helps in reducing the rate of absenteeism and accident rates.

Training

Employees are given adequate training in order to make them familiar with the

work for which he/she is selected. Both on the job and off the job training is

given to the employees. Through training employees are imparted with the

basic knowledge and skills for the effective performance of job.

Promotion

Promotion is granted to the employees on the basis of performance on their

respective jobs. Experience is also taken in to consideration while granting

promotion to employees.

Remuneration system

Remuneration package of Unichem lab is fixed in accordance with the common

industrial standards. The fixation and disbursement of remuneration is

entrusted with the personal department.

The components of employee remuneration in Unichem Laboratry

are as follows

1. Salary/Wages

2. Provident fund

3. Bonus

4. Labor welfare fund


The contribution to P.F. and bonus are done in accordance with section 5 of the

employees PF and miscellaneous act of 1952. The remuneration to workers is

subject to revise after negotiation between union and management. Percentage

increment is made after discussion with unions.

Attendance Control

The company issues an attendance card to every general worker, which

contains particular columns for each day of every month. The security at the

gate will mark the attendance in the card and in the register, which is kept with

him .Particular registers are maintained for managerial staff. Total attendance is

calculated with this card in every month and wages and overtime wages are

calculated.

Leave

The company provides total of 13 days public holidays plus Sundays in a year.

Sick leaves are also allowed to workers for sufficient period. Maternity leave is

allowed to women workers.

Other welfare facilities

First Aid

The company is maintaining a first aid box, which contains first aid medicines.

Uniform

The company provides uniform to all the employees in the organization. The

uniform of managerial and general workers is different


Healthy and Safety

The company provides all the necessary facilities to protect the health of its

employees. Strict hygienic measures are being observed inside the factory.

Employees who deals directly with chemicals are provides with gumboots,

Hand glows and masks.

Recreation

The company organizes an annual meet of its employees every year. It includes

cultural activities performed by the employees.


POLICIES:-

Environmental Policy

To manufacture and market pharmaceutical formulations and active pharmaceutical

ingredients of requisite standards to comply with customer needs, enhance customer

satisfaction and continuously improve the effectiveness of the Environmental

Management System.

We shall be a responsible care company for the environment by promoting

environment, complying applicable environmental regulations and prevention of

pollution in all our operations, including planning for energy saving and conservation

of natural resources.

Quality Policy

To manufacture and market pharmaceutical formulations and active pharmaceutical

ingredients of requisite standards to comply with customer needs, enhance customer

satisfaction and continuously improve the effectiveness of the Quality Management

System.

This shall be achieved by implementing the practices in processes and systems,

updating and conforming to applicable regulatory requirements, continuous and

dynamic improvements in quality of products and services.

Certificates:-

The Company has received ISO 9001:2000 for all its plants and corporate office.

Similarly the Company has received ISO14001:1996 certificates for its formulation

plants ( Goa, Ghaziabad and Baddi) and Corporate Office at Mumbai.


SWOT ANALYSIS

STRENGTHS

1. Low cost of production.

2. Large pool of installed capacities

3. Efficient technologies for large number of Generics.

4. Large pool of skilled technical manpower.

5. Increasing liberalization of government policies.

WEAKNESS

1. Lack of experience to exploit efficiently the new patent regime.

2. Very low key R&D.

3. Lack of experience in International Trade.

OPPORTUNITIES

1. Growing incomes resulting in getting batter medical facilities

2. Growing attention for health.

3. New diagnoses and new social diseases.

4. Saturation point of market is far away.

5. New therapy approaches.

6. New delivery systems.

7. Spreading attitude for soft medication .

8. Globalization

9. Easier international trading

10. New markets are opening.

.

THREATS

1. Containment of rising health-care cost.

2. High Cost of discovering new products and fewer discoveries.

3. High entry cost in newer markets.

4. High cost of sales and marketing.

5. Competition, particularly from generic products.


DESIGN OF THE STUDY:-

LABOUR TURNOVER IN THE UNICHEM

OBJECTIVE OF THE PROJECT TOPIC:-

This project is an attempt to deep and thorough approach toward labour turnover in

the industries.

As in the present scenario of business world, many companies are facing high

employee turnover rate and are being affected by it. So this project is tending to find

out that what actually the turnover means, what are its cause and effects and how to

control the labour turnover. Some points are listed below which can be considered as

the objective of this project topic:-

To identify areas and activities that has the greatest potential benefits in

retaining employee.

To discover what is of most concern to your employee, and therefore the

greatest risk to loosing them.

To learn the reasons your employees stay to continue and improve in these

areas.

How to improve your organization with the specific feedback from the tool

and become more attractive to current and potential employees.


Topic summary

Labour turnover is a universal problem among the industrial workers. It means

movements, shifting or migration of workers from one unit to another or from

one industry to another.

Turnover is a relatively simple and easily described concept. However

considerable confusion often results when addressing turnover, because of

differences in how it is defined, how it is counted and how the turnover rate

are expressed?

Turnover is also costly although not enough attention is paid to its cost

because so much of it is indirect and thus not readily visible. There are

varieties of causes of turnover, some which can be corrected and some which

can not be avoided.

Reducing are other wise controlling turnover require continuing management

attention to its causes and constant recognition of what can be and should be

controlled and what can not be controlled. On going attention to turnover is an

essential part of the department manager’s role.

From the control point of view the causes of labour turnover may be either

avoidable or unavoidable. Avoidable causes are those which can be controlled

by the management and unavoidable causes cannot be controlled by the

management.


EMPLOYEE TURNOVER

Turnover is a human resource context refer to the characteristics of a given company

or industry relative to rate at which an employer gain or losses staff.

According to Abassi et. Al. (2000):

Employee turnover is the rotation of workers around the labour market; between

firms, jobs and occupations; and between the states of employment and

unemployment.

According to Price (1977):

The term “Turnover” is defined as the ratio of the numbers of organizational members

who have left during the period being considered divided by the average number of

people in that organization during the period.

According to T N Chabra:

Labour turnover may be defined as the rate of change in the working staff of a

concern during a definite period.

No of separations in a year

Labour Turnover Rate:- -------------------------------------------- × 100

Average no. of workers in a year


FINDING(CAUSE OF LABOUR TURNOVER):-

Either employees leave on there own accord per they discharged. Neither fact should

be accepted submissively. Every separation of an employee from an organization,

weather voluntary or involuntary is serious for the organization.

From the control point of view, the causes of labour turnover may be either avoidable

or unavoidable.

Avoidable causes:- among the avoidable causes redundancy is the most

important which may be caused by seasonal character of the trade or business,

shortage of material, inadequate planning, lack of management foresight and

determination etc.

The other avoidable causes are:-

1. Employee dissatisfaction with job.

2. Low remuneration.

3. Long hours of work.

4. Poor working condition.

5. Bad relation with supervisor and fellow workers.

Unavoidable causes:- The unavoidable causes are not due tp the fault of

management but are due to other factors which are not under its control.

Employee may leave because of the following unavoidable reasons:-

1. Personal betterment.

2. Illness, accidents etc.

3. Domestic affaires like marriage, pregnancy in case of female employees etc.

4. Departure from the locality.

5. Unsuitable for job or misconduct on his part.

6. Housing or transport problem.

7. Retirement; death etc.


DATA COLLECTION:-

1. Employee’s data base.

2. From internet.

3. From newspaper and magazine.

4. From survey.

LIMITATION OF THE STUDY.

Many constraints were involved in doing this study. Some of them are as

follows.

Time and money are critical factors limiting this study.

The data provided by the company may not be 100% correct as the

company have limitation in supplying their own data.

Finding and suggestion have been given from personal point of view.

Due to work pressure, detailed interaction with the executives was not

possible.


CALCULATION OF EMPLOYEE TURNOVER RATE IN

UNICHEM LABS. LTD. BADDI:-

Employee Turnover in 2005:-

Total number of left employee in 2005 = 53

Average number of employees in 2005 = 98

Total No. of Separation in a year

Attrition Rate = ---------------------------------------------------------- × 100

Average No. of employees in that year

53

Attrition Rate in 2005 = -------------------- × 100 = 55 %

98


Total number of left employees in 2006 = 76

Average number of employees in 2006 =112

76

Attribution Rate in 2006 = ---------------× 100 = 68 %

112



Total number of left employees in 2007 = 40

Average number of employees in 2007 = 131

40

Attrition Rate in 2007 = ------------× 100 = 31 %

131


SUGGESTION

1. To understand the need of employees

2. Identification of the potential employees of the organization.

3. To identify the reasons for leaving.

4. To develop the career progression path.

5. To bridge the gap in term of salary.

6. To recognize the employees in the organization.

7. To enrich the job of the employees.

8. To enhance the knowledge and skill of the employees

EMPLOYEE RETENTION PLAN

Background:-

It has been seen from the past record that the employees are leaving the organization.

The attribution rate of the management staff is 33.8%. During 2005-06. it is the need

of hour to implement the plan to reduce the attrition rate.

Objective :-

1. To retain the key performers

2. To reduce the attrition rate in the management cadre by 25% from the previous

year.

Reasons for leaving:-

1. For career growth (opportunity for advancement).

2. For higher compensation.

Retention Strategies:-

1. Environmental strategies create and maintain a workplace that attracts, retain and

nourishes good people.

2. Relationship strategies focus on how you treat your people and how they treat each

other.

3. Support strategies involve giving people the tools equipment and information to get

the job done.

4. Growth strategies deal with personal and professional growth.

5. Compensation strategies cover the broad spectrum of total compensation, not just

pay and salary.


IMPLEMENTATION OF THE PLAN:-

1. Environmental strategies:-

a) Creation of rewards for recognition.

b) To give the feeling of respect & appreciation.

c) To understand their needs.

d) To respect the commitments made to employees.

2. Relationship strategies:-

In order to understand the feeling of the new employee, it is recommended to spend

more time for interaction with the new employees.

3. Growth strategies:-

Create the annual growth plan for each employee.


CONCLUSION

Turnover does not mean all the time that employee is leaving the organization

voluntarily. Sometimes employees leave the organization involuntarily.

No doubt, every organization has some strengths which make their edge from others,

but every organization have some weaknesses also.

As far as the matter of turnover is concerned, this is a great problem in present days.

People are always looking for growth opportunities and increase in there salary. So it

is very tough job to retain there employees for a long time.

From the survey done by me I concluded some points which can fix or decrease the

problem of turnover up to certain limit. The points are listed below:-

Way to heart goes through stomach’ is an old saying. In today’s world, it has

become a basic thing for the HR Managers to learn. Good food in the

companies and factories earn rule and goodwill from employees, while the bad

food creates a lot of ill will and recur in the offices and work premises.

Some employees feel that there should be equal respect for all level of workers

and there ideas should be recognized. This indicates that managers should

generate a feeling of belongingness among the worker to reduce the turnover

in the company.

Some employees feel that there is a great difference in the salary structure of

the employees as compared to other companies.

Communication gap is also a reason for conflicts in the companies which may

result in to increased employee turnover.

Some employees were of the view that the job satisfaction decreases due to

improper training and lack of knowledge, which would increase the employee

turnover. So there should be proper training of the employees.

Among these respondents maximum were of the 25-35 age group. Also from

the left employee report it was found that people of the age 25-35 years leave


the job readily. This is due to the fact that they are on the growth stage of their

career. So they leave the organization for career growth and better salary.

According to “Labour Law Reporter” females are more stable on their job as

compare to the males. Because male require more growth in their career.

Emergence of online jobs portal such as: Timesjobs.com, naukri.com,

monster.com and clickjob.com have contributed to higher employee turnover.

According to survey conducted by “Labour Law Reporter” companies, which

are in the process of expanding, face the higher attrition rate as compare to

others.

From the observations and findings, a proper plan to retain the employees is

formulated and explained in the following pages.


BIBLIOGRAPHY

1. Business Newspaper & Magzine.

2. Marketing – Philip Kotler 7th edition.

3. Business World March 2007.

4. Company Annual Employee Reports.

WEB SITES:-

www.unichemindia.com

www.google.com

www.guruji.com


http://www.guruji.com/

http://www.google.com/

http://www.unichemindia.com/

QUESTIONARIE

1. Name in Full: …………………………………………..

2. Department: .....……………………………………….

JOB DETAIL:-

1. Date of joining Unichem: - …………………………………………………………

2. Designation on joining: - ……………………………………….………………

3. When you were first employed, where the duties and responsibilities explained to

you?

Yes / No ………………………………………………….…………………

4. During your working with us was your job properly supervised?

Yes / No ……………………………………………………………………

5. Describe something that you liked while working with Unichem.

…………………………………………………………………………………………

6. Anything which you dislike while working with Unichem. ………………………

…………………………………………………………………………………………

7. Did you get an opportunity for personal professional growth? …………………..

…………………………………………………………………………………………


8. Did you get an opportunity to implement your ideas? Give details.

…………………………………………………………………………………………

9. Was the overall treatment in the organization fair and impartial ? Give detail.

…………………………………………………………………………………………

10. While working, did you get all cooperation and guidance from your superior?

Give detail.

…………………………………………………………………………………………

11. While working did you get the support you needed from your colleagues and give

details.

…………………………………………………………………………………………

12. Are you happy with the salary you getting ?

…………………………………………………………………………………………

13. What suggestion you have to make the organization a batter place of work?

…………………………………………………………………………………………

14. What policies and practices of the organization good and we should continue them?

…………………………………………………………………………………………

15. What policies and practices of our organization are not that good and that

we should discontinue? ………………………………………………………

Date: - ………………….. Signature: … …………..


unichem final project report

Documents